Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederinvestor.lilly.com
Eli Lilly and Company News Releases
Get the latest updates from Eli Lilly and Company News Releases directly as they happen.
Follow now 229 followers
Latest posts
Last updated about 19 hours ago
FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
about 19 hours ago
Averaging up to 20% of weight loss, adults taking Zepbound had at...
Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease
4 days ago
China is the fourth major market where Kisunla has received approval Kisunla...
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
4 days ago
This milestone stems from the companies' collaboration to expand access to affordable...
Lilly's Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease
8 days ago
The Phase 3 VIVID-1 trial evaluated the safety and efficacy of Omvoh...
Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer
10 days ago
As monotherapy, imlunestrant significantly reduced the risk of progression or death by...
Phase 3 results for Lilly's Jaypirca® (pirtobrutinib) in covalent BTK inhibitor pre-treated chronic lymphocytic leukemia or small lymphocytic lymphoma to be presented at the 2024 ASH Annual Meeting
12 days ago
Results from BRUIN CLL-321 show Lilly's pirtobrutinib reduced the risk of disease...
Lilly announces new $15 billion share repurchase program and seventh consecutive 15% dividend increase
12 days ago
INDIANAPOLIS , Dec. 9, 2024 /PRNewswire/ -- Today, the board of directors...
CORE Kidney, Boehringer Ingelheim and Lilly Are Turning Up the Volume on Kidney Health at the 2025 Tournament of Roses® Parade
12 days ago
Pro Football Hall of Famer Brian Dawkins joins the team to motivate...
Lilly announces $3 billion expansion of its recently acquired manufacturing facility in Wisconsin
16 days ago
The investment will benefit millions of patients worldwide, boosting the production of...
Lilly's Zepbound® (tirzepatide) superior to Wegovy® (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%
17 days ago
Participants using Zepbound lost 50.3 lbs (22.8 kg) and participants on Wegovy...
Lilly announces changes on board of directors
about 1 month ago
INDIANAPOLIS , Nov. 19, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high risk for cardiovascular events by up to 85% at highest tested dose
about 1 month ago
Muvalaplin, an oral, once-daily treatment that inhibits lipoprotein(a) formation via a novel...